TiMe Day

TiMe Day Symposium | Thursday, November 18th, 2021

The Tissue Microenvironment (TiMe) Day Symposium will be held on Thursday, November 18th, 2021 8:30 a.m. to 4:00 p.m, in 1005 Beckman and the Beckman atrium.

Agenda

Time start Time end Topic
8:15 AM 9:00 AM Registration, breakfast, and poster setup
9:00 AM 9:10 AM Welcome: Rohit Bhargava, Cancer Center at Illinois (CCIL) Director, and H. Rex Gaskins, CCIL Associate Director for Education
9:10 AM 9:15 AM Introduce/Speaker Change
9:15 AM 9:55 AM Plenary talk 1 and Q/A: Viktor Gruev, Professor of Electrical and Computer Engineering
9:55 AM 10:00 AM Introduce Keynote/Speaker Change
10:00 AM 11:00 AM Keynote Speaker: Amy LeBlanc, Director, Comparative Oncology Program, Center for Cancer Research, National Cancer Institute
11:00 AM 12:30 PM Poster session
12:00 PM 1:00 PM Lunch
1:00 PM 1:05 PM Introduce/Speaker Change
1:05 PM 2:00 PM TiME Trainees Poster Session
2:00 PM 2:05 PM Break
2:05 PM 2:45 PM Plenary talk 2 and Q/A: Gabriel Popescu, Professor of Electrical and Computer Engineering
2:45 PM 2:50 PM Introduce/Speaker Change
2:50 PM 3:20 AM TiME Trainees Lightning Talks
3:20 AM 3:45 PM Award Ceremony and Closing Remarks

 

Speakers:

Keynote Speaker: Amy K. LeBlanc, DVM, Diplomate ACVIM (Oncology), Director, Comparative Oncology Program, Center for Cancer Research, NationalCancer Institute, National Institutes of Health

Amy LeBlanc is a board-certified veterinary oncologist and the Director of the intramural National Cancer Institute’sComparative Oncology Program. In this position she conducts preclinical mouse and translational canine studies that are designed to inform the drug and imaging agent development path for human cancer patients. She also advises leading pharmaceutical companies as well as NCI’s Division of Cancer Treatment and Diagnosis on the inclusion of pet dogs with cancer into the development path of novel approaches for a variety of malignancies, including immunotherapeutics, targeted small molecules, oncolytic viruses, and cancer imaging agents. She directly oversees the NCI Comparative Oncology Trials Consortium (COTC), which provides infrastructure necessary to connect participating veterinary academic institutions with stakeholders in drug development to execute fit-for-purpose comparative clinical trials in novel therapeutics and imaging agents.

Plenary Speaker: Viktor Gruev, Professor of Electrical and Computer Engineering

Viktor Gruev’s lab focuses on borrowing key concepts from nature to develop ultra sensitive, compact, and conformal imaging
sensors capable of recording spectral and polarization properties with high spatial resolution, and to bring these new sensory devices to clinical settings such as cancer detection. His near-infrared fluorescence goggle technology has been used in breast cancer clinical trials in patients with breast cancer. The ultimate goal of his research is to bring medical imaging technology to resource-limited hospitals and the developing world.

Plenary Speaker: Gabriel Popescu, Professor of Electrical and Computer Engineering

Gabriel Popescu has been studying phase measurements and interferometry for twenty years, resulting in breakthrough publications, news articles, and patent licensing for
diffraction phase microscopy. Popescu’s lab has pushed the bounds of technology and applications through the development of SLIM, a white light method that is speckle-free, and thus highly sensitive to structure and dynamics. SLIM enabled unprecedented studies, generating ~50 publications on prostate prognosis, cell tomography, emerging behavior in neuron networks, blood testing, cancer prognosis, and imaging thick specimens. Currently, Popescu’s lab aims to advance interferometric imaging technology toward quantitative cancer prognosis in stained biopsies.

 

Poster Instructions

  • Standard 3′ by 4′ poster
  • Check with the registration table to identify which board to use to hang your poster
  • There will be push pins at the registration table
  • Hang your poster by 10:00 a.m.
  • Take down your poster by 4:00 p.m.